Laiping Zhong

7PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2026
The emerging role of neoadjuvant immunotherapy in locally advanced oral squamous cell carcinoma: progress and challenges.

Tong-Chao Zhao, Yi-Bin Dai, Zhi-Hang Zhou

|Oct 07, 2024
Nomogram to Predict Nodal Recurrence-Free Survival in Early Oral Squamous Cell Carcinoma.

Ying Liu, Limin Liu, Yining He

|Sep 14, 2022
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.

Wu-Tong Ju, Rong-Hui Xia, Dong-Wang Zhu

|Jan 20, 2021
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.

Wu-Tong Ju, Ying Liu, Li-Zhen Wang

|May 26, 2020
High-risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer.

Tong-Chao Zhao, Si-Yuan Liang, Wu-Tong Ju

|Jan 30, 2020
Stathmin guides personalized therapy in oral squamous cell carcinoma.

Wu-Tong Ju, Hai-Long Ma, Tong-Chao Zhao

Pageof 2

Frequent Collaborators

1 joint publications

Wu-Tong Ju

1 joint publications

Guo-Pei Zhu

1 joint publications

Ying Liu

1 joint publications

Yingying Huang